On Monday, Vaxcyte Inc (NASDAQ: PCVX) opened lower -45.64% from the last session, before settling in for the closing price of $69.46. Price fluctuations for PCVX have ranged from $58.10 to $121.06 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -18.65% at the time writing. With a float of $125.07 million, this company’s outstanding shares have now reached $128.76 million.
In an organization with 414 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Vaxcyte Inc (PCVX) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Vaxcyte Inc is 2.86%, while institutional ownership is 107.92%. The most recent insider transaction that took place on Mar 05 ’25, was worth 353,699. In this transaction SVP, GEN COUNSEL & CORP SEC of this company sold 5,000 shares at a rate of $70.74, taking the stock ownership to the 41,620 shares. Before that another transaction happened on Mar 05 ’25, when Company’s Officer proposed sale 5,000 for $68.87, making the entire transaction worth $344,350.
Vaxcyte Inc (PCVX) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.97 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -18.65% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -5.44% during the next five years compared to -29.88% drop over the previous five years of trading.
Vaxcyte Inc (NASDAQ: PCVX) Trading Performance Indicators
Check out the current performance indicators for Vaxcyte Inc (PCVX). In the past quarter, the stock posted a quick ratio of 12.75.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.88, a number that is poised to hit -1.04 in the next quarter and is forecasted to reach -4.60 in one year’s time.
Technical Analysis of Vaxcyte Inc (PCVX)
Let’s dig in a bit further. During the last 5-days, its volume was 3.49 million. That was better than the volume of 1.35 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 19.66%. Additionally, its Average True Range was 5.93.
During the past 100 days, Vaxcyte Inc’s (PCVX) raw stochastic average was set at 8.90%, which indicates a significant decrease from 16.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 250.36% in the past 14 days, which was higher than the 106.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $79.14, while its 200-day Moving Average is $89.06. However, in the short run, Vaxcyte Inc’s stock first resistance to watch stands at $40.43. Second resistance stands at $43.09. The third major resistance level sits at $48.25. If the price goes on to break the first support level at $32.61, it is likely to go to the next support level at $27.45. Assuming the price breaks the second support level, the third support level stands at $24.79.
Vaxcyte Inc (NASDAQ: PCVX) Key Stats
There are currently 128,762K shares outstanding in the company with a market cap of 4.86 billion. Presently, the company’s annual sales total 0 K according to its annual income of -463,930 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -137,080 K.
